DE1643310A1
(de)
|
1966-12-29 |
1971-06-03 |
Dow Chemical Co |
4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
|
US4099012A
(en)
*
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
DE2926517A1
(de)
*
|
1979-06-30 |
1981-01-15 |
Beiersdorf Ag |
Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
|
DE2928485A1
(de)
*
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
IL61721A
(en)
*
|
1980-12-16 |
1984-03-30 |
Blank Izhak |
Nitroglycerin preparations
|
US4555399A
(en)
*
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
US4985352A
(en)
*
|
1988-02-29 |
1991-01-15 |
The Trustees Of Columbia University In The City Of New York |
DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
EP0412798A3
(en)
|
1989-08-08 |
1992-07-01 |
Merck Sharp & Dohme Ltd. |
Substituted pyridines, their preparation, formulations and use in dementia
|
US5661024A
(en)
*
|
1989-10-31 |
1997-08-26 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
|
US5128351A
(en)
*
|
1990-05-04 |
1992-07-07 |
American Cyanamid Company |
Bis-aryl amide and urea antagonists of platelet activating factor
|
US5077409A
(en)
*
|
1990-05-04 |
1991-12-31 |
American Cyanamid Company |
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
|
JPH04334357A
(ja)
|
1991-05-02 |
1992-11-20 |
Fujirebio Inc |
酵素阻害作用を有するアシル誘導体
|
FR2682379B1
(fr)
*
|
1991-10-09 |
1994-02-11 |
Rhone Poulenc Agrochimie |
Nouveaux phenylpyrazoles fongicides.
|
FR2690440B1
(fr)
*
|
1992-04-27 |
1995-05-19 |
Rhone Poulenc Agrochimie |
Arylpyrazoles fongicides.
|
DE69411176T2
(de)
*
|
1993-08-20 |
1998-11-12 |
Smithkline Beecham Plc |
Amide und harnstoffderivate als 5ht1d rezeptor antagonisten
|
FR2722369B1
(fr)
|
1994-07-13 |
1998-07-10 |
Rhone Poulenc Agrochimie |
Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
|
EP0784612A1
(en)
|
1994-10-04 |
1997-07-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
CA2135253A1
(en)
|
1994-11-07 |
1996-05-08 |
Michael Dennis |
Compound screening based on a window of chemical-messenger-independent activity
|
KR19980701879A
(ko)
*
|
1995-02-02 |
1998-06-25 |
피터 기딩스 |
5-히드록시트립타민 수용체 길항제로서의 인돌 유도체
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
JPH11503110A
(ja)
*
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体拮抗剤
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
ES2149471T3
(es)
|
1995-04-20 |
2000-11-01 |
Eurand Int |
Compuesto con glicolato de almidon sodico como material soporte y productos a base de dicho compuesto.
|
US5861431A
(en)
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
AU6526896A
(en)
|
1995-07-22 |
1997-02-18 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
US6054472A
(en)
*
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
*
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
GB9607219D0
(en)
*
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
AU2962297A
(en)
|
1996-05-24 |
1998-01-05 |
Neurosearch A/S |
Phenyl derivatives useful as blockers of chloride channels
|
DE69716424T2
(de)
*
|
1996-05-24 |
2003-02-20 |
Neurosearch A/S, Ballerup |
Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
|
PL330849A1
(en)
*
|
1996-06-27 |
1999-06-07 |
Smithkline Beecham Corp |
Antagonists of il-8 receptors
|
WO1998000133A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
|
US6204285B1
(en)
|
1996-07-01 |
2001-03-20 |
Sepracor Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate
|
ES2255103T3
(es)
*
|
1996-10-25 |
2006-06-16 |
Shire Laboratories Inc. |
Sistema osmotico de administracion de dosis en forma soluble.
|
JP2001508767A
(ja)
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
5―ht拮抗作用を有するインドール―ウレア誘導体
|
US6420541B1
(en)
*
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6541209B1
(en)
*
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
US6696475B2
(en)
*
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
BR9808938A
(pt)
*
|
1997-04-22 |
2000-08-01 |
Neurosearch As |
Composto, composição farmacêutica, uso de um composto, processos para o tratamento de um distúrbio ou doença de um corpo de animal vivo e para a preparação de um composto, e, uso de bloqueadores de canal de cloreto
|
US6028083A
(en)
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
EP1000017A4
(en)
|
1997-07-29 |
2000-10-18 |
Smithkline Beecham Corp |
ANTAGONISTS OF THE IL-8 RECEPTOR
|
ZA987800B
(en)
*
|
1997-08-27 |
1999-06-09 |
Hexal Ag |
Pharmaceutical composition of meloxicam
|
AU748041B2
(en)
*
|
1997-10-31 |
2002-05-30 |
Aventis Pharma Limited |
Substituted anilides
|
JPH11183942A
(ja)
|
1997-12-19 |
1999-07-09 |
Nippon Mitsubishi Oil Corp |
エレクトロクロミック素子
|
JP3887769B2
(ja)
|
1997-12-22 |
2007-02-28 |
バイエル コーポレイション |
対称および非対称ジフェニル尿素を用いるp38キナーゼの阻害
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
KR100704977B1
(ko)
|
1997-12-22 |
2007-04-09 |
바이엘 코포레이션 |
대칭성 및 비대칭성 치환디페닐우레아를 이용한 raf키나제의 저해
|
ES2156845T1
(es)
*
|
1998-04-14 |
2001-08-01 |
Arena Pharm Inc |
Receptores de serotonina humana no endogenos constitutivamente activados y moduladores de moleculas pequeñas para estos.
|
US6140509A
(en)
*
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
GB9816263D0
(en)
*
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6358698B1
(en)
*
|
1998-10-07 |
2002-03-19 |
Acadia Pharmacueticals Inc. |
Methods of identifying inverse agonists of the serotonin 2A receptor
|
AP2001002103A0
(en)
*
|
1998-10-22 |
2001-03-31 |
Neurosearch As |
Substituted phenyl derivatives, their preparation and use.
|
US6150393A
(en)
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
US6180138B1
(en)
*
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
IL145508A0
(en)
|
1999-03-26 |
2002-06-30 |
Euro Celtique Sa |
Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
|
GB9909409D0
(en)
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
US6469006B1
(en)
|
1999-06-15 |
2002-10-22 |
Bristol-Myers Squibb Company |
Antiviral indoleoxoacetyl piperazine derivatives
|
IT1312115B1
(it)
*
|
1999-06-24 |
2002-04-04 |
Nicox Sa |
Composti amorfi e relative composizioni farmaceutiche
|
DE60041584D1
(de)
|
1999-07-28 |
2009-04-02 |
Aventis Pharma Inc |
Substituierte oxoazaheterozyclische verbindungen
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
US6531291B1
(en)
*
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
EP1108720A1
(en)
|
1999-12-08 |
2001-06-20 |
Basf Aktiengesellschaft |
Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
|
EP1248770A1
(en)
|
1999-12-16 |
2002-10-16 |
Biostream Therapeutics |
1,3,4-substituted piperidine analogs and uses thereof in treating addictions
|
CA2397681C
(en)
|
1999-12-20 |
2011-03-15 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
AU2001241927A1
(en)
|
2000-02-28 |
2001-09-12 |
Scios Inc. |
Inhibitors of p38-alpha kinase
|
FR2810979B1
(fr)
*
|
2000-06-29 |
2002-08-23 |
Adir |
Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
AR035521A1
(es)
|
2000-12-22 |
2004-06-02 |
Lundbeck & Co As H |
Derivados de 3-indolina y composicion farmaceutica que los comprende
|
WO2002055496A1
(en)
|
2001-01-15 |
2002-07-18 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
WO2002076464A1
(en)
|
2001-03-22 |
2002-10-03 |
Arena Pharmaceuticals, Inc. |
Anti-psychosis combination
|
AU2002321061B2
(en)
|
2001-06-29 |
2006-08-24 |
Eurand Pharmaceuticals Ltd |
Process of thermodynamical activation of water-insoluble drugs loaded into cross linked polymers
|
JP4733877B2
(ja)
|
2001-08-15 |
2011-07-27 |
富士通セミコンダクター株式会社 |
半導体装置
|
CN104744461A
(zh)
*
|
2001-09-21 |
2015-07-01 |
百时美施贵宝公司 |
含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
|
WO2003062206A2
(en)
|
2002-01-23 |
2003-07-31 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
US6743864B2
(en)
|
2002-03-12 |
2004-06-01 |
Basell Poliolefine Italia S.P.A. |
Polyolefin compositions having high tenacity
|
AU2003298514A1
(en)
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
AU2003275093A1
(en)
|
2002-09-24 |
2004-04-19 |
Arena Pharmaceuticals, Inc. |
Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
AU2003290638A1
(en)
|
2002-11-08 |
2004-06-03 |
Interdigital Technology Corporation |
Composite channel quality estimation techniques for wireless receivers
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
US20060229335A1
(en)
*
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
PT1587789E
(pt)
|
2003-01-16 |
2008-12-16 |
Acadia Pharm Inc |
Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas
|
CA2515544A1
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
JP2006521345A
(ja)
|
2003-03-28 |
2006-09-21 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
ニコチン性アセチルコリン受容体の正のアロステリック調節剤
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
SI1558582T1
(sl)
|
2003-07-22 |
2006-06-30 |
Arena Pharm Inc |
Diaril in arilheteroaril secninski derivati kot modulatorji 5-HT2A serotoninskega receptorja, koristnega za profilakso in zdravljenje motenj, ki so znjim povezane
|
ATE313532T1
(de)
*
|
2003-07-22 |
2006-01-15 |
Arena Pharm Inc |
Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
|
JP2005046121A
(ja)
*
|
2003-07-31 |
2005-02-24 |
Japan Science & Technology Agency |
オンチップバイオアッセイ方法及びキット
|
JP2007502287A
(ja)
|
2003-08-13 |
2007-02-08 |
アムジェン インコーポレイテッド |
メラニン凝集ホルモン受容体アンタゴニスト
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
US20050054691A1
(en)
*
|
2003-08-29 |
2005-03-10 |
St. Jude Children's Research Hospital |
Carboxylesterase inhibitors
|
JP2007504220A
(ja)
|
2003-09-03 |
2007-03-01 |
ガラパゴス・エヌブイ |
イミダゾ[1,5−a]ピリジン又はイミダゾ[1,5−a]ピペリジン誘導体および5HT2A受容体関連障害に対する薬剤の製造のためのその使用
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
US20070293539A1
(en)
|
2004-03-18 |
2007-12-20 |
Lansbury Peter T |
Methods for the treatment of synucleinopathies
|
CN1926114B
(zh)
*
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
WO2006004722A2
(en)
*
|
2004-06-30 |
2006-01-12 |
Biomol Research Laboratories, Inc. |
Compositions and methods for selectively activating human sirtuins
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
EP1786422A2
(en)
|
2004-08-16 |
2007-05-23 |
Prosidion Limited |
Aryl urea derivatives for treating obesity
|
US20060063754A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Edgar Dale M |
Methods of treating a sleep disorder
|
WO2006045010A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
JP2008518014A
(ja)
|
2004-10-27 |
2008-05-29 |
ニューロゲン コーポレイション |
Cb1拮抗薬としてのジアリール尿素
|
WO2006049734A2
(en)
|
2004-10-29 |
2006-05-11 |
Hypnion, Inc. |
Quetiapine analogs and methods of use thereof
|
ATE491456T1
(de)
|
2004-11-01 |
2011-01-15 |
Seo Hong Yoo |
Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
|
SA05260357B1
(ar)
*
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
AR051978A1
(es)
|
2004-12-01 |
2007-02-21 |
Divergence Inc |
Composiciones plaguicidas y metodos
|
US20080015223A1
(en)
*
|
2004-12-03 |
2008-01-17 |
Arena Pharmaceuticals, Inc. |
Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
|
DE102004061593A1
(de)
|
2004-12-21 |
2006-06-22 |
Abbott Gmbh & Co. Kg |
Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
|
EP1831172B1
(en)
|
2004-12-28 |
2009-02-18 |
Council of Scientific and Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
US7625931B2
(en)
|
2005-01-14 |
2009-12-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted diphenyl ureas, as modulators of kinase activity
|
CN101160127A
(zh)
*
|
2005-01-19 |
2008-04-09 |
艾尼纳制药公司 |
用于预防或治疗进行性多灶性白质脑病而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
|
US20060188569A1
(en)
|
2005-01-21 |
2006-08-24 |
Teva Pharmaceutical Industries Ltd. |
Stable pharmaceutical formulations of zonisamide and methods for their manufacture
|
AR052886A1
(es)
*
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
WO2006079637A1
(en)
|
2005-01-27 |
2006-08-03 |
Janssen Pharmaceutica N.V. |
Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0505437D0
(en)
|
2005-03-17 |
2005-04-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0505725D0
(en)
|
2005-03-19 |
2005-04-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
ES2341127T3
(es)
|
2005-04-26 |
2010-06-15 |
Hypnion, Inc. |
Compuestos de bencisoxazol-piperazina y procedimiento de uso.
|
EP1734039A1
(en)
|
2005-06-13 |
2006-12-20 |
Esbatech AG |
Aryl urea compounds as BETA-secretase inhibitors
|
KR101363278B1
(ko)
|
2005-06-27 |
2014-02-21 |
엑셀리시스 페이턴트 컴퍼니 엘엘씨 |
이미다졸계 lxr 변조제
|
US7754724B2
(en)
|
2005-06-30 |
2010-07-13 |
Dow Agrosciences Llc |
N-substituted piperazines
|
US8093401B2
(en)
*
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US7544685B2
(en)
|
2005-08-17 |
2009-06-09 |
H. Lundbeck A/S |
2,3-dihydroindole compounds
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
EP1928430A1
(en)
|
2005-09-29 |
2008-06-11 |
Arena Pharmaceuticals, Inc. |
Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
|
WO2007120600A2
(en)
|
2006-04-10 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
GB0608655D0
(en)
|
2006-05-03 |
2006-06-14 |
Merck Sharp & Dohme |
Therapeutic Treatment
|
USRE45336E1
(en)
*
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
CA2646076C
(en)
*
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
WO2007136875A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
MX2008014622A
(es)
|
2006-05-18 |
2008-11-28 |
Arena Pharm Inc |
Formas cristalinas y procesos para la preparacion de fenil-pirazoles utiles como moduladores del receptor de serotonina 5-ht2a.
|
WO2008027483A1
(en)
|
2006-08-31 |
2008-03-06 |
Arena Pharmaceuticals, Inc. |
Benzofuran derivatives as modulators of the 5-ht2a receptor
|
TWI415845B
(zh)
*
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
TW200823204A
(en)
*
|
2006-10-17 |
2008-06-01 |
Arena Pharm Inc |
Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
US9034890B2
(en)
|
2006-11-15 |
2015-05-19 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
US8969402B2
(en)
|
2006-11-15 |
2015-03-03 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
US8097633B2
(en)
|
2006-11-15 |
2012-01-17 |
Rich Steven A |
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
|
EP2121621B1
(en)
|
2006-12-08 |
2014-05-07 |
Exelixis Patent Company LLC |
Lxr and fxr modulators
|
ES2421237T7
(es)
|
2007-08-15 |
2013-09-30 |
Arena Pharmaceuticals, Inc. |
Derivados de imidazo[1,2-a]piridin como moduladores del receptor serotoninérgico 5ht2a en el tratamiento de trastornos relacionados con el mismo
|
AU2008302079A1
(en)
|
2007-09-21 |
2009-03-26 |
Acadia Pharmaceuticals, Inc. |
Co-administration of pimavanserin with other agents
|
WO2009074607A1
(en)
|
2007-12-12 |
2009-06-18 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
WO2010062321A1
(en)
*
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
ES2666324T3
(es)
|
2008-10-28 |
2018-05-04 |
Arena Pharmaceuticals, Inc. |
Composiciones de un modulador del receptor de serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con el mismo
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
WO2013188210A2
(en)
|
2012-06-11 |
2013-12-19 |
Psychogenics, Inc. |
Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
|
JOP20210047A1
(ar)
|
2012-10-25 |
2017-06-16 |
Otsuka Pharma Co Ltd |
عامل وقائي و/أو علاجي للأعراض السلوكية والنفسية المصحوبة بمرض تنكسي عصبي أو الأعراض الإندفاعية المصحوبة بمرض ذهني، يحتوي على بريكسبيرازول أو ملحه
|
US9446037B2
(en)
|
2012-11-27 |
2016-09-20 |
Acadia Pharmaceuticals Inc. |
Methods for the treatment of parkinson's disease psychosis using pimavanserin
|
KR101472682B1
(ko)
|
2013-07-23 |
2014-12-15 |
고려대학교 산학협력단 |
메타물질 제조 방법, 이에 의해 제조된 메타물질 구조 필름 및 이를 이용한 광학 이미징 시스템
|
IL305990A
(en)
|
2013-12-03 |
2023-11-01 |
Intra Cellular Therapies Inc |
Compressed gamma-carboline heterocyclic compounds are modified for use in the treatment of type I and/or type II bipolar disorders
|
US20150313903A1
(en)
|
2014-05-05 |
2015-11-05 |
Ovid Therapeutics Inc. |
Methods of treating cognitive impairment associated with neurodegenerative disorders
|
WO2016201373A1
(en)
|
2015-06-12 |
2016-12-15 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder
|
CN108472285A
(zh)
|
2015-07-15 |
2018-08-31 |
阿速万科学有限责任公司 |
用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
|
WO2018148737A1
(en)
|
2017-02-13 |
2018-08-16 |
Axovant Sciences Gmbh |
5-ht2a serotonin receptor serotonin receptor inverse agonists useful for the prophylaxis and treatment of parkinsonian symptoms associated with a neurodegenerative disease
|
US20190046506A1
(en)
|
2017-08-10 |
2019-02-14 |
Axovant Sciences Gmbh |
Use of 5ht2a inverse agonists for treating psychosis
|